Cited by 108Atherosclerosis and Cardiovascular DiseasesEicosanoids and Hypertension PharmacologyInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis

LOTZER, K, FUNK, C, HABENICHT, A·2005·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

DOI 10.1016/j.bbalip.2005.07.001

Open this paper in CoChat — free account

Abstract

Leukotrienes (LTs) are powerful inflammatory lipid mediators derived from the 5-lipoxygenase (5-LO) cascade of arachidonic acid. Recent clinical, population genetic, cell biological, and mouse studies indicate participation of the 5-LO pathway in atherogenesis and arterial wall remodeling. 5-LO is expressed by leukocytes including blood monocytes, tissue macrophages, dendritic cells, neutrophils, and mast cells. LTB4 and the cysteinyl LTs LTC4, LTD4, and LTE4, act through two BLT and two cysLT receptors that are differentially expressed on hematopoietic and arterial wall cells. The precise roles of LTs or the LT receptors in cardiovascular physiology remain largely to be explored. In this review, we will discuss what is currently known about the 5-LO atherosclerosis connection. We will attempt to propose strategies to further explore potential links between the 5-LO pathway and blood vessel physiology and disease progression.

Integrity signals

Registry

Crossref · 10.1016/j.bbalip.2005.07.001

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Self-citation
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. O. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,839
Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.
Dahlén, S., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 975
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O’Neill, G. P., Liu, Q., Im, D., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
Helgadóttir, A., Manolescu, A. R., Þorleifsson, G., Grétarsdóttir, S., Jonsdottir, H., Þorsteinsdóttir, U., Samani, N. J., Gudmundsson, G. H., Grant, S. F. A., Þorgeirsson, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1311 · Cited by 923
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Heise, C. E., O’Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003490200 · Cited by 660
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 623
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
Drazen, J. M., Yandava, C., Dubé, L. M., Szczerbak, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N. J., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 561

Show all 51 references

Sorted by citations

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Zheng, W., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,538
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function
Fialkow, L., Wang, Y., & Downey, G. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.030 · Cited by 723
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Inflammatory networks in ageing, age-related diseases and longevity
Vasto, S., Candore, G., Balistreri, C. R., Caruso, M., Colonna‐Romano, G., Grimaldi, M. P., Listı̀, F., Nuzzo, D., Lio, D., & Caruso, C. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.015 · Cited by 481
5-Lipoxygenase: regulation of expression and enzyme activity
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. O. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.002 · Cited by 468
Monocyte recruitment and foam cell formation in atherosclerosis
Bobryshev, Y. V. (2005) · Micron · doi:10.1016/j.micron.2005.10.007 · Cited by 379
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 333
Self-citation
CVD and Oxidative Stress
Cervantes-Gracia, K., Llanas-Cornejo, D., & Husi, H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020022 · Cited by 320
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Charo, I. F., & Taub, R. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3444 · Cited by 314
Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease
Zhou, Y., Khan, H. Z., Xiao, J., & Cheang, W. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112029 · Cited by 196
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
Poeckel, D., & Funk, C. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq016 · Cited by 185
Self-citation
International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions
Bäck, M., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004184 · Cited by 160
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 145
The effects of dietary flavonoids on the regulation of redox inflammatory networks
Izzi, V. (2012) · Frontiers in bioscience · doi:10.2741/4061 · Cited by 137
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2012) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 118
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A 4 production
Rakonjac, M., Fischer, L., Provost, P., Werz, O., Steinhilber, D., Samuelsson, B. O., & Rådmark, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605150103 · Cited by 106
Leukotrienes Are Essential for the Control of Leishmania amazonensis Infection and Contribute to Strain Variation in Susceptibility
Serezani, C. H., Perrela, J. H., Russo, M., Peters-Golden, M. L., & Jancar, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3201 · Cited by 99
Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells
Uzonyi, B., Lötzer, K., Jahn, S., Krämer, C., Hildner, M., Bretschneider, E., Radke, D., Beer, M., Vollandt, R., Evans, J. F., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601223103 · Cited by 98
Self-citation
Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies
Rai, G., Joshi, N., Jung, J. E., Liu, Y., Schultz, L., Yasgar, A., Perry, S., Diaz, G., Zhang, Q., Kenyon, V. A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401915r · Cited by 97
Phosphoinositide and Inositolpolyphosphate Signalling in Defense Responses of Arabidopsis thaliana Challenged by Mechanical Wounding
Mosblech, A., König, S., Stenzel, I., Grzeganek, P., Feußner, I., & Heilmann, I. (2008) · Molecular Plant · doi:10.1093/mp/ssm028 · Cited by 83
Peripheral arterial occlusive disease: Global gene expression analyses suggest a major role for immune and inflammatory responses
Fu, S., Zhao, H., Shi, J., Abzhanov, A., Crawford, K. D., Lucila Ohno-machado, A., Zhou, J., Du, Y., Kuo, W. P., Zhang, J., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-369 · Cited by 81
Occurrence of azo food dyes and their effects on cellular inflammatory responses
Leo, L., Loong, C., Ho, X. L., Raman, M. F. B., Suan, M. Y. T., & Loke, W. M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.010 · Cited by 79
Leukotrienes: Mediators that have been typecast as villains
Flamand, N., Mancuso, P., Serezani, C. H., & Brock, T. G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7228-2 · Cited by 70
Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury
Adhikari, N., Charles, N. J., Lehmann, U., & Hall, J. L. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0081-1 · Cited by 66
mPGES-1 and ALOX5/-15 in tumor-associated macrophages
Weigert, A., Strack, E., Snodgrass, R. G., & Brüne, B. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9731-3 · Cited by 62
Lipoxygenase Pathways as Mediators of Early Inflammatory Events in Atherosclerosis
Funk, C. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222960.43792.ff · Cited by 62
Self-citation
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field
Hoxha, M., Rovati, G. E., & Bueno‐Cavanillas, A. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2242-2 · Cited by 60
Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease
Assimes, T. L., Knowles, J. W., Priest, J. R., Basu, A., Volcik, K. A., Southwick, A. M., Tabor, H. K., Hartiala, J., Allayee, H., Grove, M. L., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0489-5 · Cited by 60
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
Riccioni, G., Zanasi, A., Vitulano, N., Mancini, B., & D’Orazio, N. (2009) · Mediators of Inflammation · doi:10.1155/2009/737282 · Cited by 58
Cyclooxygenase- and lipoxygenase-mediated DNA damage
Speed, N., & Blair, I. A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9298-8 · Cited by 58
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?
Yedgar, S., Krimsky, M., Cohen, Y., & Flower, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.07.005 · Cited by 55
Hypertensive Pressure Mechanosensing Alone Triggers Lipid Droplet Accumulation and Transdifferentiation of Vascular Smooth Muscle Cells to Foam Cells
Swiatlowska, P., Tipping, W. J., Marhuenda, E., Severi, P., Fomin, V., Yang, Z., Xiao, Q., Graham, D., Shanahan, C. M., & Iskratsch, T. (2023) · Advanced Science · doi:10.1002/advs.202308686 · Cited by 52
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice
Zhou, Y., Crichton, I., Tang, S. Y., Hui, Y., Ricciotti, E., Levin, M. D., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115313109 · Cited by 54
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension
Sacerdoti, D., Pesce, P., Pascoli, M. D., Brocco, S., Cecchetto, L., & Bolognesi, M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.008 · Cited by 50
Cysteinyl leukotriene 2 receptor‐mediated vascular permeability via transendothelial vesicle transport
Moos, M. P. W., Mewburn, J. D., Kan, F. W. K., Ishii, S., Abe, M., Sakimura, K., Noguchi, K., Shimizu, T., & Funk, C. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-113274 · Cited by 50
Self-citation
Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study
Burdon, K. P., Rudock, M. E., Lehtinen, A. B., Langefeld, C. D., Bowden, D. W., Register, T. C., Liu, Y., Freedman, B. I., Carr, J. J., Hedrick, C. C., et al. (2010) · Mediators of Inflammation · doi:10.1155/2010/170153 · Cited by 46
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study
Girelli, D., Martinelli, N., Trabetti, E., Olivieri, O., Cavallari, U., Malerba, G., Busti, F., Friso, S., Pizzolo, F., Pignatti, P. F., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201854 · Cited by 43
Arachidonic Acid Metabolites in the Cardiovascular System: The Role of Lipoxygenase Isoforms in Atherogenesis With Particular Emphasis on Vascular Remodeling
Kühn, H., Chaitidis, P., Roffeis, J., & Walther, M. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318159f177 · Cited by 43
Oxylipin formation in Nostoc punctiforme (PCC73102)
Lang, I., & Feußner, I. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.02.028 · Cited by 42
Lipidic last breath of life in patients with alcoholic liver disease
Raszeja‐Wyszomirska, J., Safranow, K., Milkiewicz, M., Milkiewicz, P., Szynkowska, A., & Stachowska, E. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.06.001 · Cited by 41
Novel quinolinone–pyrazoline hybrids: synthesis and evaluation of antioxidant and lipoxygenase inhibitory activity
Kostopoulou, I., Diassakou, A., Kavetsou, E., Kritsi, E., Zoumpoulakis, P. G., Pontiki, E. A., Hadjipavlou‐Litina, D., & Detsi, A. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10045-x · Cited by 40
Role of Sp1 in atherosclerosis
Jiang, J.-F., Zhou, Z., Liu, Y.-Z., Wu, L., Nie, B.-B., Huang, L., & Zhang, C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07516-9 · Cited by 39
Targeted Chiral Analysis of Bioactive Arachidonic Acid Metabolites Using Liquid-Chromatography-Mass Spectrometry
Mesaros, C., & Blair, I. A. (2012) · Metabolites · doi:10.3390/metabo2020337 · Cited by 37
ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation
Stephensen, C. B., Armstrong, P., Newman, J. W. I., Pedersen, T. L., Legault, J., Schuster, G. U., Kelley, D. S., Vikman, S., Hartiala, J., Nassir, R., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p012864 · Cited by 37
Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice
Cao, R. Y., Adams, M. A., Habenicht, A. J. R., & Funk, C. D. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.03.005 · Cited by 35
Self-citation
Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems
Lee, S. H., & Blair, I. A. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.7.401 · Cited by 33
Discovery of Boolean metabolic networks: integer linear programming based approach
Qiu, Y., Jiang, H., Ching, W., & Cheng, X. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0528-3 · Cited by 32
4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase
Yun, M. R., Im, D., Lee, S. J., Park, H. M., Bae, S. S., Lee, W. S., & Kim, C. D. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.12.013 · Cited by 31
Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis
Lubrano, V., Ndreu, R., & Balzan, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021637 · Cited by 33
Plant sterol-enriched soy milk consumption modulates 5-lipoxygenase, 12-lipoxygenase, and myeloperoxidase activities in healthy adults – a randomized-controlled trial
Ho, X. L., Liu, J. J. H., & Loke, W. M. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1252839 · Cited by 30
Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
Uz, T., Dimitrijević, N., Imbesi, M., Manev, H., & Manev, R. M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.041 · Cited by 30
IFN-γ Induces Cysteinyl Leukotriene Receptor 2 Expression and Enhances the Responsiveness of Human Endothelial Cells to Cysteinyl Leukotrienes
Woszczek, G., Chen, L., Nagineni, S., Alsaaty, S., Harry, A., Logun, C., Pawliczak, R., & Shelhamer, J. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5262 · Cited by 30
The current view on the role of leukotrienes in atherogenesis.
Jawień, J., & Korbut, R. (2010) · PubMed · Cited by 29
A ‘Desaturase Hypothesis’ for Atherosclerosis: Janus-Faced Enzymes in ω–6 and ω–3 Polyunsaturated Fatty Acid Metabolism
Martinelli, N., Consoli, L., & Olivieri, O. (2009) · Lifestyle Genomics · doi:10.1159/000238177 · Cited by 27
5-Lipoxygenase-mediated Endogenous DNA Damage
Jian, W., Lee, S. H., Williams, M. V., & Blair, I. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011841 · Cited by 26
LPS Increases 5-LO Expression on Monocytes via an Activation of Akt-Sp1/NF-κB Pathways
Lee, S. J., Seo, K. W., & Kim, C. D. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.3.263 · Cited by 25
Quantitation of leukotriene B4 in human sputum as a biomarker using UPLC–MS/MS
Jian, W., Edom, R. W., Xue, X., Huang, M., Fourie, A. M., & Weng, N. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.06.010 · Cited by 24
Ascorbic acid 6-palmitate: a potent inhibitor of human and soybean lipoxygenase-dependent lipid peroxidation
Mohamed, R., Tarannum, S., Manjunath, Y., Kameshwar, V. H., Siddesha, J. M., Angaswamy, N., & Vishwanath, B. S. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12200 · Cited by 24
GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site
Dishart, D., Schnur, N., Klan, N., Werz, O., Steinhilber, D., SAMUELSSON, B., & Rådmark, O. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.11.008 · Cited by 24
The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells
Finkensieper, A., Kieser, S., Bekhite, M. M., Richter, M., Mueller, J. P., Gräbner, R., Figulla, H., Sauer, H., & Wartenberg, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp385 · Cited by 22
Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Listı̀, F., Caruso, M., Incalcaterra, E., Hoffmann, E., Caimi, G., Balistreri, C. R., Vasto, S., Scafidi, V., Caruso, C., & Candore, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786264115 · Cited by 21
Products of 5-lipoxygenase and myeloperoxidase activities are increased in young male cigarette smokers
Loke, W. M., Lam, K. M.-J., Chong, W. L., Chew, S. E., Quek, A. M. L., Lim, E. C. H., & Seet, R. C. S. (2012) · Free Radical Research · doi:10.3109/10715762.2012.701291 · Cited by 20
Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
Merhi, M., Demirdjian, S., Hariri, E. H., Sabbah, N., Youhanna, S. C., Ghassibe‐Sabbagh, M., Naoum, J. J., Haber, M., Othman, R., Kibbani, S., et al. (2015) · Inflammation Research · doi:10.1007/s00011-015-0821-1 · Cited by 20
Metabolism of 5-hydroxy-6,8,11,14-eicosatetraenoic acid by human endothelial cells
Erlemann, K.-R., Cossette, C., Gravel, S., Stamatiou, P. B., Lee, G., Rokach, J., & Powell, W. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.011 · Cited by 20
The effects of oral Cardax™ (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo
Lockwood, S. F., Penn, M. S., Hazen, S. L., Bikádi, Z., & Zsila, F. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.052 · Cited by 19
Synthesis and Antioxidant Activities of Novel Pyrimidine Acrylamides as Inhibitors of Lipoxygenase: Molecular Modeling and In Silico Physicochemical Studies
Saragatsis, M. A., & Pontiki, E. A. (2024) · Molecules · doi:10.3390/molecules29061189 · Cited by 18
Genetic Variants in the Promoter Region of the ALOX5AP Gene and Susceptibility of Ischemic Stroke
Ji, R., Jia, J., Ma, X., Wu, J., Zhang, Y., & Xu, L. (2011) · Cerebrovascular Diseases · doi:10.1159/000330341 · Cited by 17
The putative role of leukotrienes in experimental atherogenesis
Jawień, J. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.620 · Cited by 17
A metabolomics study on effects of polyaromatic compounds in oil sand extracts on the respiratory, hepatic and nervous systems using three human cell lines
Sarma, S. N., Kimpe, L. E., Doyon, V. C., Blais, J. M., & Chan, H. M. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108680 · Cited by 15
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases
Fortunato, G., & Taranto, M. D. D. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.018 · Cited by 15
HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression
Jang, E. J., Baek, S. E., Kim, E., Park, S. Y., & Kim, C. D. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.04.001 · Cited by 14
Arachidonic acid is associated with dyslipidemia and cholesterol-related lipoprotein metabolism signatures
Li, F., Wang, Y., Yu, H., Gao, X., Li, L., Sun, H., & Qin, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1075421 · Cited by 14
Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection
Loke, W. M., Chow, A. Y., Sing, K. L. M., Lee, J. C., Halliwell, B. B., Lim, E. C. H., Quek, A. M. L., Ooi, E. E., & Seet, R. C. S. (2013) · Virology Journal · doi:10.1186/1743-422x-10-322 · Cited by 14
5‐Lipoxygenase Gene Variants Are Not Associated With Atherosclerosis or Incident Coronary Heart Disease in the Multi‐Ethnic Study of Atherosclerosis Cohort
Tsai, M. Y., Cao, J., Steffen, B. T., Weir, N. L., Rich, S. S., Liang, S., & Guan, W. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002814 · Cited by 13
Novel Multi-Target Agents Based on the Privileged Structure of 4-Hydroxy-2-quinolinone
Kostopoulou, I., Tzani, A., Chronaki, K., Prousis, K. C., Pontiki, E. A., Hadjipavlou‐Litina, D., & Detsi, A. (2023) · Molecules · doi:10.3390/molecules29010190 · Cited by 12
Myeloid Cell 5-Lipoxygenase Activating Protein Modulates the Response to Vascular Injury
Zhou, Y., Ricciotti, E., Miwa, T., Liu, S., Ihida‐Stansbury, K., Landesberg, G. P., Jones, P. L., Scalia, R. G., Song, W., Assoian, R. K., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.300755 · Cited by 12
5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells
Lötzer, K., Jahn, S., Krämer, C., Hildner, M., Nüsing, R. M., Funk, C. D., & Habenicht, A. J. R. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.04.005 · Cited by 11
Self-citation
Promoter methylation and functional variants in arachidonate 5‐lipoxygenase and forkhead box protein O1 genes associated with coronary artery disease
Heidari, L., Ghaderian, S. M. H., Vakili, H., & Salmani, T. A. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28501 · Cited by 10
2D-3D Mixed Face Recognition Schemes
Rama, A., Tarrs, F., Rurainsky, J., & Eisert, P. (2008) · InTech eBooks · doi:10.5772/6398 · Cited by 10
Is There a Role for the Macrophage 5‐Lipoxygenase Pathway in Aortic Aneurysm Development in Apolipoprotein E–Deficient Mice?
Funk, C. D., Cao, R. Y., Zhao, L., & Habenicht, A. J. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1383.012 · Cited by 10
Self-citation
Hydrolysis of lipoproteins by sPLA2’s enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2’s IIA, V and X
Pruzanski, W., Kopilov, J., & Kuksis, A. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.12.004 · Cited by 8
The Genetics of Innate Immunity and Inflammation in Ageing, Age-Related Diseases and Longevity
Caruso, C., Balistreri, C. R., Crivello, A., Forte, G. I., Grimaldi, M. P., Listı̀, F., Scola, L., Vasto, S., & Candore, G. (2008) · Springer eBooks · doi:10.1007/978-0-387-76842-7_14 · Cited by 8
BLTR1 in Monocytes Emerges as a Therapeutic Target For Vascular Inflammation With a Subsequent Intimal Hyperplasia in a Murine Wire-Injured Femoral Artery
Baek, S. E., Park, S. Y., Bae, S. S., Kim, K., Lee, W. S., & Kim, C. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01938 · Cited by 7
The role of leukotriene B4 in early stages of experimental paracoccidioidomycosis induced in phenotypically selected mouse strains
Balderramas, H. D. A., Ribeiro, O. G., Soares, Â. M. V. D. C., & de Oliveira, S. L. (2013) · Medical Mycology · doi:10.3109/13693786.2013.777163 · Cited by 7
New fatty acids, oxylipins and volatiles in microalgae
Lang, I. (2007) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-243 · Cited by 7
Functional variants of the human 5-lipoxygenase gene and their genetic diagnosis
Geiger, E. V., Doehring, A., Kirchhof, A., & Lötsch, J. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.04.001 · Cited by 6
5-Lipoxygenase in monocytes emerges as a therapeutic target for intimal hyperplasia in a murine wire-injured femoral artery
Baek, S. E., Jang, M. A., Lee, S. J., Park, S. Y., Bae, S. S., & Kim, C. D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.012 · Cited by 6
Interleukin-1β inhibits synthesis of 5-lipooxygenase in lipopolysaccharide-stimulated equine whole blood
Mangal, D., Uboh, C. E., Jiang, Z., & Soma, L. R. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.01.001 · Cited by 5
The development of methodology for clinical measurement of 5-lipoxygenase pathway intermediates from human peripheral blood mononuclear cells
Willey, M. B., Alborn, W. E., Lutzke, B. S., LeLacheur, R. M., White, R. J., Stavrakis, G., Konrad, R. J., & Ackermann, B. L. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.09.034 · Cited by 5
Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study
Sutton, S. S., Magagnoli, J., Cummings, T. H., & Hardin, J. W. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106649 · Cited by 3
Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice
Keever, K., & Askari, B. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100203 · Cited by 2
ALOX5AP gene variants show differential association with coronary artery disease in different populations
Alwan, A. A., Youhanna, S. C., Platt, D. E., El‐Sibai, M., Yerezian, J. S., Deeb, M. E., Khazen, G., Saadé, S., Zreik, T. G., el Bayeh, H., et al. (2010) · Journal of Community Genetics · doi:10.1007/s12687-010-0015-z · Cited by 2
Genetic analyses of circulating PUFA-derived mediators identifies heritable dihydroxyeicosatrienoic acid species
McGurk, K. A., Farrell, L. N., Kendall, A. C., Keavney, B. D., & Nicolaou, A. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106638 · Cited by 2
Mouse Models of Experimental Atherosclerosis as a Tool for Checking a Putative Anti-Atherogenic Action of Drugs
Jawień, J. (2012) · InTech eBooks · doi:10.5772/26071 · Cited by 2
Analysis of Genetic Variants in the Glucocorticoid Receptor Gene NR3C1 and Stenosis of the Carotid Artery in a Polish Population with Coronary Artery Disease
Gorący, J., Gorący, A., Wójcik-Grzeszczuk, A., Gorący, I., & Rosik, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081912 · Cited by 1
Prostaglandins and Leukotrienes
Lötzer, K., & Habenicht, A. J. R. (2008) · Wiley eBooks · doi:10.1002/9783527626236.ch13
Self-citation
The nuclear factor k[kappa]B signal transduction pathway : Its role in atherogenesis and intimal hyperplasia
Bu, D.-X. (2006) · Figshare
Identification and molecular characterization of a novel splice variant of human 5- lipoxygenase gene
Singh, A. K., Kumar, R. K., Shukla, A. A., Hariprasad, G., Chauhan, S. S., & Dey, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3732-2
Role of -463G/A Promoter Polymorphism of Myeloperoxidase in the Development of Atherosclerosis
Mäkelä, R. (2009) · Tampere University Institutional Repository (Tampere University)

Authors: LOTZER, K., FUNK, C., & HABENICHT, A.
Affiliations: Queen's University (CA)
Friedrich Schiller University Jena (DE)
Corresponding author: HABENICHT, A
ORCID: FUNK, C
HABENICHT, A
Venue: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Publisher: Elsevier BV
Published: 2005-07-21
Volume: 1736
Issue: 1
Pages: 30-7
ISSN: 1388-1981 (ISSN-L)
DOI: 10.1016/j.bbalip.2005.07.001
OpenAlex: W2132989642
Cited by: 108
References: 51
Citations by year: 2024: 2 · 2023: 3 · 2022: 6 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 10
FWCI: 4.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
National Institutes of Health (2r01hl058464-04)
National Heart, Lung, and Blood Institute (HL 58464)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords: 5-lipoxygenase, leukotrienes, atherosclerosis, atherogenesis, arterial remodeling, leukotriene B4, cysteinyl leukotrienes, cysteinyl leukotriene receptor, arachidonic acid metabolism, leukocytes, inflammation
MeSH terms: Animals, Arachidonate 5-Lipoxygenase, Arteries, Arteriosclerosis, Signal Transduction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks